Diabetic muscle infarction (DMI) is a rare complication of long-standing poorly controlled diabetes mellitus. We herein describe the case of a 56-year-old man with a 10-year history of poorly controlled type 2 diabetes mellitus with multiple microvascular and macrovascular complications who presented with the sudden onset of left thigh pain and swelling. MRI suggested muscle infarction. A muscle biopsy demonstrated coagulation necrosis in the skeletal muscle with inflammation and infarction in the walls of small blood vessels. Physicians should consider DMI in the differential diagnosis of patients with diabetes who present with painful, swollen muscles without systemic signs of infection.
Introduction
Diabetic muscle infarction (DMI) is a rare and often unrecognized complication of diabetes mellitus. It typically occurs in patients with poorly controlled and multicomplicated diabetes (1, 2) . The typical clinical presentation includes indurate muscle pain primarily localized in the lower limbs with acute onset (1) . We herein report a case of multifocal DMI occurring in a 56-year-old man with type 2 diabetes and degenerative complications and discuss its clinical features, pathogenesis, diagnosis and prognosis.
Case Report
A 56-year-old man with a 10-year history of poorly controlled type 2 diabetes was evaluated for acute recurrent pain lasting for one month in his left thigh, which was swollen and caused him great difficulty in moving. The patient had multiple diabetic complications, including microalbuminuria, nonproliferative retinopathy, sensory polyneuropathy confirmed on electromyography and a history of previous amputation of the right fifth toe due to peripheral arterial disease. He denied any history of traumatic injury, animal bites or muscular injections into the left thigh. On a physical examination, he was found to be afebrile with diffuse swelling of the left proximal thigh and a 10×15-cm palpable, tender mass in the posteromedial region of the affected extremity. The patient's thigh was warm to the touch, without erythema or skin changes. There were no systemic symptoms. The laboratory data were significant for a blood glucose level of 270 mg/dL and a HbA1c level of 11.6%, as shown in the Table. A complete blood count revealed normocytic normochromic anemia with moderate leukocytosis. The serum creatinine kinase (CK) level was elevated at 852 IU/L. In addition, a biological inflammatory syndrome was detected (erythrocyte sedimentation rate: 135 mm/h, CRP: 84.6 mg/L, fibrinogen: 6.8 mg/L). However, the serum creatinine level was normal (0.9 mg/dL), and blood cultures and antiphospholipid antibodies were negative. Ultrasonography demonstrated extensive subcutaneous edema of the posterior and medial compartment of the left thigh. Color Doppler ultrasonography revealed no evidence of deep venous thrombosis. The patient was initially treated with in- 
travenous antibiotics for a presumptive diagnosis of pyomyositis or necrotizing fasciitis, with no improvements in his condition. Magnetic resonance imaging (MRI) was performed, which disclosed isointense swelling on T1-weighted images and diffuse hyperintensity on T2-weighted images of the rectus femoris, gracilis, sartorius and adductor muscles (Fig. 1 ). MRI performed with intravenous gadolinium revealed non-enhancing large areas in the left adductor muscle, indicative of necrosis, surround by peripheral enhancement (Fig. 2 ). An examination of a biopsy specimen of the left thigh muscle showed diffuse edema with hemorrhage, large patchy areas of coagulation necrosis and inflammation surrounding blood vessels, consistent with an ischemic process (Fig. 3) . A culture of the biopsy specimen was negative. Based on these findings, the patient was diagnosed with DMI. Complete bed rest was advised, and the patient was given symptomatic treatment with analgesics, antiplatelets and subcutaneous insulin injection. After two weeks of hospitalization, his symptoms regressed; he was able to walk and subsequently discharged. In addition, a significant improvement was obtained in various blood parameters (CRP: 18 mg/L, CK: 102 IU/L), with a stable glycemic profile. No recurrence of symptoms was observed during six months of follow-up.
Discussion
The present patient exhibited typical features of DMI, including acute onset of focal leg pain, followed by tenderness and swelling. MRI visualized the multifocal infarct, and a muscle biopsy confirmed hemorrhagic necrosis of the muscle. The patient had poorly controlled diabetes mellitus and was hyperglycemic at the time of infarction. DMI is a rare complication that is usually reported in association with long-standing poorly controlled diabetes mellitus, particularly type 1 diabetes, with known late complications, such as nephropathy, retinopathy and neuropathy (1-3). Although first described in 1965, less than 200 cases have been reported in the literature (1, 4) . The paucity of cases may be the result of unfamiliarity with this rare condition among clinicians. The patient described in this case report had uncontrolled type 2 diabetes mellitus with associated microvascular and macrovascular complications, which have been reported previously to be risk factors for DMI (1) (2) (3) (4) (5) .
The typical presentation of DMI includes acute onset pain in the affected muscle, local swelling and, occasionally, a palpable mass, without any prior history of trauma (1, 3, 4, 6) . Fever is uncommon, and, if present, one should actively look for an infective pathology (7). The thigh muscles are affected in 81% to 87% of cases, and the calf in 13% to 19% of cases, with bilateral involvement in approximately 40% of patients (8) . The most commonly involved muscles are the quadriceps (62%), hip adductors (13%), hamstrings (8%) and hip flexor muscles (2%). DMI of the calf and upper extremity muscles is less common (9) . In the present case, the area of infarction was multifocal, in- volving more than three muscle groups in the thigh.
Laboratory studies generally demonstrate an elevated erythrocyte sedimentation rate and normal or mildly elevated white blood cell count in affected patients. Measurements of CK may be normal or elevated depending on the timing of blood sampling and amount of muscle involved (10) .
MRI is the diagnostic test of choice for DMI and makes it possible to confirm the diagnosis without performing a muscular biopsy. MRI typically shows isointense swelling on T1-weighted images and diffuse heterogeneous hyperintensity on T2-weighted images of the affected muscle, with surrounding subfascial and subcutaneous edema. Gadolinium contrast reveals non-enhancing areas surrounded by peripheral enhancement (11). MRI also makes it possible to exclude other diseases that mimic DMI, which can be difficult to diagnose clinically. The differential diagnosis includes deep venous thrombosis, thrombophlebitis, abscesses, pyomyositis, spontaneous hematomas, sarcoma, necrotic fasciitis, myositis, osteomyelitis, cellulitis and primary lymphoma (1-3, 5) .
The gold standard for diagnosis is a biopsy of the muscle, although this procedure carries a risk of delayed healing and superimposed infection. Muscle biopsies are reserved for patients in whom the diagnosis is uncertain and those with an atypical presentation or who do not improve with appropriate treatment (2, 5) . Typical biopsy findings reveal muscle fiber necrosis, inflammatory cell infiltration and microvascular abnormalities, as observed in this current case (5) .
The pathogenesis of DMI remains unclear. It has been suggested that reperfusion injury after muscle ischemia results in muscle infarction, as almost all patients with DMI experience microangiopathic complications of diabetes mellitus. In addition, the presence of endothelial dysfunction in patients with diabetes mellitus in addition to hypercoagulability resulting from alterations in the coagulationfibrinolytic system has been proposed (6, 10, 12). However, due to the rarity of the condition, the association between antiphospholipid antibody syndrome and DMI has not been proven (10) . In the present case, no abnormalities in the coagulation system or levels of phospholipid antibodies were detected.
The mainstay of treatment for DMI involves early recognition, bed rest, analgesics and aggressive control of diabetes mellitus. Other modalities suggested to be beneficial include the administration of low-dose aspirin, pentoxifylline, nifedipine, dipyridamole, nonsteroidal agents and anticoagulants. However, there are no randomized control trials to support the use of these agents (6, 10, 12) . In general, the short-term prognosis is reported to be benign, although the long-term outcome is discouraging. Several patients have been reported to have died within two years after being diagnosed with DMI, mostly due to vascular complications associated with diabetes mellitus (1). In one study, the prognosis of DMI among patients with diabetes mellitus was reported to be similar to that observed after myocardial infarction, with both conditions invariably involving significant vascular injury (13) .
In conclusion, DMI is a rare but significant complication of diabetes mellitus with an overall poor long-term outcome. The incidence of this condition is likely to increase as a result of the increasing global prevalence of diabetes. Physicians should consider DMI in the differential diagnosis of patients with diabetes who present with painful, swollen muscles without systemic signs of infection. MRI is the diagnostic test of choice for evaluating DMI.
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